A two year open-label study from the USA on the use of Epidyolex in treatment resistant epilepsy has reported positive findings.
In advance of their annual conference which is taking place today, the Irish Epilepsy League ran a competition for health science students to write a creative essay in prose/ poetry about epilepsy. The competition was open-ended and could be based on an experience in real-life; an experience through their training; or fictional stories from the patient's perspective.
A new study aimed at developing a preconception care pathway for women with epilepsy in the UK is seeking feedback from women with epilepsy based in Northern Ireland.
While the evenings are getting longer and the sun a bit brighter, we still need to continue to #HoldFirm with measures to combat COVID-19.
With all children set to return to school next week, we have published our updated Epilepsy and School Booklet.
At the meetng of Donegal County Council earlier this week, Councillors supported a motion on the issue of Free Travel for People with epilepsy.
A new anti-epileptic drug has received marketing authorisation from the European Commission to allow the manufacturers to make the drug available in member states.
ONTOZRY® (also know as Cenobamate) is a medication indicated for use in the treatment of drug-resistant focal-onset seizures in adults.